Circadian rhythm: from preclinical to post-diagnosis dementia
The RHYTHM IN DEMENTIA project aims to identify circadian rhythm features linked to dementia risk and progression, using accelerometry and biomarkers to inform prevention strategies.
Projectdetails
Introduction
Circadian rhythm (CR) regulates body functions over the 24-hour day/night period; the sleep/wake cycle is its most visible manifestation. CR disruptions have long been observed in patients with dementia, and emerging evidence points to their presence in the preclinical period of dementia.
Significance of CR in Dementia
This suggests that certain aspects of CR could be useful in the identification of high-risk individuals and could serve as potential targets for interventions to delay dementia onset and progression. This requires an in-depth understanding of the role of CR in dementia pathogenesis.
Need for Strategies
As population ageing increases dementia burden, it is critical to find strategies to identify patients at risk of dementia with precision, prevent, and slow its progression.
Project Overview
Building on recent advances in accelerometry (to assess CR features comprehensively) and dementia biomarkers (deep-phenotyping of dementia pathogenesis), RHYTHM IN DEMENTIA will make a decisive step-change in knowledge by determining CR features involved in dementia processes along the course of the disease.
Aims of the Project
The aims are:
- Identify core CR features that shape 10-year risk of dementia in a community-dwelling cohort of 4000 older adults.
- Uncover specific CR disruptions that characterize major dementia subtypes and stages of Alzheimer’s disease (determined by biomarkers) in a new cohort of 1500 patients recruited from two memory clinics in Paris.
- Ascertain how CR affects dementia prognosis in the patient cohort by examining cognitive and functional decline, hospitalization, institutionalization, and mortality.
Expected Outcomes
This project will yield new insight into the nature of the association between CR and dementia progression. These findings will ultimately inform the potential for a cost-effective and easy-to-use tool to assess CR features to facilitate both the identification of patients at risk of dementia and tailored secondary prevention interventions that address CR disruptions in dementia patients and slow the progression of dementia.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.999.982 |
Totale projectbegroting | € 1.999.982 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 30-4-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting the circadian clock in personalized disease preventionThis project aims to identify and mitigate health risks associated with disrupted circadian rhythms in night workers through genetic profiling and targeted interventions for healthier aging. | ERC Advanced... | € 2.499.965 | 2022 | Details |
Pre-commercialization of circadian clock-drug interactions screening tool for therapeutic applicationsThe CIRCOMMUNICATION project aims to commercialize CircaSCOPE, a high-throughput method for constructing Phase Transition Curves to enhance drug efficacy and minimize side effects through chronotherapy. | ERC Proof of... | € 150.000 | 2022 | Details |
Map and manipulate sleep oscillations to reveal their role in healthy cognitive developmentThis project aims to investigate the causal relationship between sleep architecture and cognitive development in young mammals using advanced neurobiological techniques to inform therapeutic strategies for developmental disorders. | ERC Starting... | € 1.500.000 | 2024 | Details |
The Silent Phase of Alzheimer’s Disease: From Brain States to Homeostatic FailuresThis project aims to uncover the mechanisms stabilizing hippocampal circuits and their relation to Alzheimer's disease by exploring homeostatic regulation across brain states using diverse experimental tools. | ERC Advanced... | € 2.500.000 | 2023 | Details |
The early ticking of the central circadian pacemaker: when and howStarTicking aims to uncover the development and functionality of the circadian clock in mice and humans, linking early environmental factors to behavioral outcomes in pre-term infants. | ERC Consolid... | € 1.955.875 | 2024 | Details |
Targeting the circadian clock in personalized disease prevention
This project aims to identify and mitigate health risks associated with disrupted circadian rhythms in night workers through genetic profiling and targeted interventions for healthier aging.
Pre-commercialization of circadian clock-drug interactions screening tool for therapeutic applications
The CIRCOMMUNICATION project aims to commercialize CircaSCOPE, a high-throughput method for constructing Phase Transition Curves to enhance drug efficacy and minimize side effects through chronotherapy.
Map and manipulate sleep oscillations to reveal their role in healthy cognitive development
This project aims to investigate the causal relationship between sleep architecture and cognitive development in young mammals using advanced neurobiological techniques to inform therapeutic strategies for developmental disorders.
The Silent Phase of Alzheimer’s Disease: From Brain States to Homeostatic Failures
This project aims to uncover the mechanisms stabilizing hippocampal circuits and their relation to Alzheimer's disease by exploring homeostatic regulation across brain states using diverse experimental tools.
The early ticking of the central circadian pacemaker: when and how
StarTicking aims to uncover the development and functionality of the circadian clock in mice and humans, linking early environmental factors to behavioral outcomes in pre-term infants.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
EEGX2Dit project ontwikkelt een softwaretool voor vroegtijdige dementiedetectie via EEG-analyse, gebruikmakend van goedkope hardware en geavanceerde algoritmes, in samenwerking met zorginstellingen. | Mkb-innovati... | € 120.943 | 2023 | Details |
twiN-on-a-chip brAins for monitoring individual sleeP habitsNAP aims to revolutionize sleep research by developing personalized in vitro models to identify sleep disorders and early Parkinson's Disease signs, enhancing diagnostics and reducing healthcare costs. | EIC Pathfinder | € 3.615.375 | 2023 | Details |
Haalbaarheid op data gebaseerde gepersonaliseerd leefstijladvies t.b.v. cognitieve gezondheidTolooba B.V. ontwikkelt een verbeterde Memory Up-applicatie die cognitieve training en gepersonaliseerd leefstijladvies combineert om geheugenverlies te bestrijden en de cognitieve gezondheid te bevorderen. | Mkb-innovati... | € 20.000 | 2023 | Details |
EEGX2
Dit project ontwikkelt een softwaretool voor vroegtijdige dementiedetectie via EEG-analyse, gebruikmakend van goedkope hardware en geavanceerde algoritmes, in samenwerking met zorginstellingen.
twiN-on-a-chip brAins for monitoring individual sleeP habits
NAP aims to revolutionize sleep research by developing personalized in vitro models to identify sleep disorders and early Parkinson's Disease signs, enhancing diagnostics and reducing healthcare costs.
Haalbaarheid op data gebaseerde gepersonaliseerd leefstijladvies t.b.v. cognitieve gezondheid
Tolooba B.V. ontwikkelt een verbeterde Memory Up-applicatie die cognitieve training en gepersonaliseerd leefstijladvies combineert om geheugenverlies te bestrijden en de cognitieve gezondheid te bevorderen.